Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 1
1948 1
1949 1
1951 1
1952 3
1953 1
1957 2
1958 2
1959 3
1960 1
1961 2
1962 2
1963 1
1964 1
1965 4
1966 2
1967 1
1968 4
1969 1
1970 1
1971 2
1972 2
1974 3
1975 4
1976 1
1977 3
1978 4
1979 2
1980 1
1981 5
1982 3
1983 1
1984 7
1985 2
1986 3
1987 3
1988 1
1989 9
1990 6
1991 5
1992 5
1993 10
1994 6
1995 9
1996 8
1997 7
1998 10
1999 3
2000 3
2001 8
2002 10
2003 9
2004 8
2005 9
2006 15
2007 13
2008 21
2009 21
2010 15
2011 20
2012 16
2013 23
2014 22
2015 18
2016 26
2017 29
2018 26
2019 29
2020 36
2021 38
2022 26
2023 31
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
The task force consisted of 32 SSc clinical experts from Europe and the USA, 2 patients nominated by the pan-European patient association for SSc (Federation of European Scleroderma Associations (FESCA)), a clinical epidemiologist and 2 research fellows. All centres from t …
The task force consisted of 32 SSc clinical experts from Europe and the USA, 2 patients nominated by the pan-European patient association fo …
Diagnosis and Treatment of Esophageal Candidiasis: Current Updates.
Mohamed AA, Lu XL, Mounmin FA. Mohamed AA, et al. Can J Gastroenterol Hepatol. 2019 Oct 20;2019:3585136. doi: 10.1155/2019/3585136. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 31772927 Free PMC article. Review.
Another group includes those who used antibiotics frequently and those who have esophageal motility disorder (cardiac achalasia and scleroderma). Patients complained of pain on swallowing, difficulty swallowing, and pain behind the sternum. ...
Another group includes those who used antibiotics frequently and those who have esophageal motility disorder (cardiac achalasia and scler …
Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M, Wu J, Wu H, Sawalha AH, Lu Q. Zhao M, et al. Clin Rev Allergy Immunol. 2022 Apr;62(2):273-291. doi: 10.1007/s12016-020-08831-4. Epub 2021 Jan 15. Clin Rev Allergy Immunol. 2022. PMID: 33449302 Review.
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive fibrosis of the skin and multiple internal organs and (ii) localized scleroderma (L …
There are two major clinical subsets of scleroderma: (i) systemic sclerosis (SSc) is a complex systemic autoimmune disorder character …
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. van den Hoogen F, et al. Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424. Ann Rheum Dis. 2013. PMID: 24092682 Free article.
The system was tested by (1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and (2) validating against the combined view of a group of experts on a set of cases with or without SSc. ...
The system was tested by (1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders, and ( …
Immunomodulatory treatment of interstitial lung disease.
van den Bosch L, Luppi F, Ferrara G, Mura M. van den Bosch L, et al. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221117002. doi: 10.1177/17534666221117002. Ther Adv Respir Dis. 2022. PMID: 35938712 Free PMC article. Review.
In ILDs other than IPF, immunosuppression is the cornerstone of therapy, with varying levels of evidence for different immunomodulatory agents and for each specific ILD. ...The treatment of acute exacerbations of ILD is also discussed. Therapy augmentation in ILD is …
In ILDs other than IPF, immunosuppression is the cornerstone of therapy, with varying levels of evidence for different immunomodulato …
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK. Mathai SC, et al. BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819. BMJ. 2016. PMID: 26912511 Free PMC article. Review.
ILD can be present in most types of CTD, including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, polymyositis or dermatomyositis, Sjogren's syndrome, and mixed connective tissue disease. ...Lung transplantation should be considered in patients with advan …
ILD can be present in most types of CTD, including rheumatoid arthritis, scleroderma, systemic lupus erythematosus, polymyositis or d …
Diagnosis and management of autoimmune diseases in the ICU.
Dumas G, Arabi YM, Bartz R, Ranzani O, Scheibe F, Darmon M, Helms J. Dumas G, et al. Intensive Care Med. 2024 Jan;50(1):17-35. doi: 10.1007/s00134-023-07266-7. Epub 2023 Dec 19. Intensive Care Med. 2024. PMID: 38112769 Review.
A distinction should be made between connective tissue diseases (mainly systemic lupus erythematosus, systemic scleroderma, inflammatory muscle diseases, and rheumatoid arthritis) and vasculitides (mainly small-vessel vasculitis such as antineutrophil cytoplasmic antibody- …
A distinction should be made between connective tissue diseases (mainly systemic lupus erythematosus, systemic scleroderma, inflammat …
Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I. Bielsa Marsol I. Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13. Actas Dermosifiliogr. 2013. PMID: 23948159 Free article. Review.
Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. ...However, classification is difficult because the boundaries between the different types of morphea are blurred and different entities fre …
Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. …
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ, Korkmaz C. Cansu DÜ, et al. Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17. Clin Rheumatol. 2023. PMID: 36396789 Review.
Key Points Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) in Western countries is the second most common type of PAH after idiopathic PAH (IPAH). CTD-PH can be seen most often in systemic scleroderma (SSc), less in systemic lupus eryt …
Key Points Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) in Western countries is the second most com …
Management of Calcinosis Cutis in Rheumatic Diseases.
Elahmar H, Feldman BM, Johnson SR. Elahmar H, et al. J Rheumatol. 2022 Sep;49(9):980-989. doi: 10.3899/jrheum.211393. Epub 2022 May 15. J Rheumatol. 2022. PMID: 35569832 Free article. Review.
584 results